The focus of the combined company is developing new treatment for rare genetic skin diseases. Palvella Therapeutics completed a reverse merger with Pieris Pharmaceutical of Boston to become a ...
After two rounds of layoffs in 2024 and slimming down its active drug development work, Ikena Oncology has decided to pursue ...
“This reverse merger represents a US$452 million transaction at a deemed price of US$3.20 per share —a significant milestone that we believe will enhance market visibility while supporting our ...
Hosted on MSN10d
nDatalyze Corp. Plans Reverse Merger with AHLDatalyze Corp (TSE:NDAT) has released an update. nDatalyze Corp. has announced a non-binding Letter of Intent to engage in a reverse takeover ...
Hepion Pharmaceuticals and Pharma Two B have terminated a reverse merger agreement that was expected to close by the end of the year. The decision was mutual, meaning neither company will have to ...
If the reverse merger is completed, the combined company will satisfy the market capitalization requirements to maintain its listing. NewGen scheduled a hearing with Nasdaq to appeal the delisting ...
NewGenIvf Group (NIVF) announced that both parties involved in the previously announced reverse merger with European Wellness Investment Holdings have appointed legal counsel to prepare the Share ...
NewGenIvf Group Ltd. NIVF, the fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, is getting closer to completing a reverse merger ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback